Biotech China 2014
World Generic Medicines Congress Americas 2012
Hyatt Regency Washington on Capitol Hill
400 New Jersey Avenue, NW
Washington, DC
http://www.healthnetworkcommunications.com/2012/generic-medicines-congress-americas/programme-day-one-wednesday-28-november-2012.stm
http://www.healthnetworkcommunications.com/2012/generic-medicines-congress-americas/programme-day-one-wednesday-28-november-2012.stm
World Generic Medicines Congress Americas 2012 
World Generic Medicine Congress
Hyatt Regency Washington on Capitol Hill
Hyatt Regency Washington on Capitol Hill

Schedule of Presentations:

Tuesday, November 27, 2012
Wednesday, November 28, 2012
06:00:00 Deep dive review of the generic and biosimilars industry and opportunities in China
08:00:00 Registration
08:45:00 Opening remarks from the chair
09:00:00 The role of generic medicines in the delivery of affordable and effective medicine to patients
09:30:00 Building value and a successful generics portfolio with a focus on Europe
10:00:00 Generic growth strategies through innovative partnering models
10:30:00 Morning refreshments & Speed networking
11:30:00 Update of US Health Care Reform and impact of recent US legislation on generics Juliana Reed
12:00:00 Key FTC actions affecting the generics industry Mark Woodward
12:30:00 Legal and patent strategies for the generics industry Stephen Auten
13:00:00 Lunch+ Lunch sessions
14:00:00 M&A environment and opportunities for generic companies Robert Steininger
14:30:00 Challenges for the industry: pricing and competition
15:00:00 Long term growth strategies for generic manufacturers Carole S. Ben-Maimon
15:30:00 Afternoon refreshments
16:00:00 Overcoming Obstacles in the Supply Chain
16:30:00 In conversation session: innovation ain generic marketing and sales – demand generation for branded generics Richard DiCicco
17:00:00 Market Dynamics in Southern Africa: The Good, The bad and The Ugly' George Proctor
18:00:00 Closing remarks followed by the networking drinks reception
Thursday, November 29, 2012
08:45:00 Opening remarks from the chair
09:00:00 Congressional update and Q&A session on US Legislation
09:30:00 Panel session: USA current and future regulatory setting for biosimilars F. Owen Fields, Carrie Burke
10:30:00 Morning refreshments
11:00:00 The global biosimilar industry of today: considerations and expectations
11:30:00 Business models for commercial success in biosimilars
12:00:00 Operational realities of building a biosimilar and biobetter development strategy
12:30:00 Lunch
13:30:00 USA market access for generic medicines: a focus on reimbursement trends from Medicaid & Medicare. Richard Gilfillan
14:00:00 Influence of generic medicines on evolutionary changes in pharmaceutical trade and wholesaling industry
14:15:00 Panel discussion: What is driving the purchasing decisions for generic medicines in the US?
14:45:00 Afternoon refreshments
15:15:00 MENA Pharma markets new post Arab spring
15:45:00 Cancer drug shortages: how can the generics sector help overcome the challenges Bruce Chabner
16:15:00 Challenges and opportunities in gaining market share from a smaller generic manufacturer perspective
16:45:00 Forecasting to aid strategic portfolio management
17:15:00 Closing remarks from the chair
17:20:00 End of conference
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.